We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Updates Exjade Label to Include Liver Warning
Novartis Updates Exjade Label to Include Liver Warning
December 21, 2007
The labeling for the iron chelator Exjade has been updated again after postmarketing reports of liver failure, sometimes resulting in death, according to an FDA MedWatch report.